Disputes on drug price system between medical and industrial communities.

The medical and drug industrial communities are sharply confronted each other over the medical insurance drug price system in which the medical side insisted on turning back to the former reported price system while the drug industry side keeping the current actual transaction price system.

In the conference meeting over "the medical insurance drug pricing reform policy" at the National Parl...